Showing results (11-20 of 93) with videos related to
Sort By:
Pageof 10
International Journal of Molecular Sciences|June 18, 2016
Immune Mechanisms in Myelodysplastic SyndromeAndreas Glenthøj, Andreas Due Ørskov, Jakob Werner Hansen, et al.Elife|May 3, 2023
Improved T cell receptor antigen pairing through data-driven filtering of sequencing information from single cellsHelle Rus Povlsen, Amalie Kai Bentzen, Mohammad Kadivar, et al.Scientific Reports|May 29, 2024
Validation of novel conditional ligands and large-scale detection of antigen-specific T cells for H-2Dd and H-2KdTrine Sundebo Meldgaard, Nadia Viborg, Sara Suarez Hernandez, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 7, 2019
Optimization in Detection of Antigen-Specific T Cells Through Differentially Labeled MHC MultimersNatasja Wulff Pedersen, Karoline Laske, Dominik Maurer, et al.Scientific Reports|November 20, 2025
Mapping real-time metabolic kinetics of expanded CAR T cells using hyperpolarized 13C-glucose and metabolomicsThomas B Wareham Mathiassen, Mikkel Rasmus Hansen, Magnus Karlsson, et al.Cancer Immunology, Immunotherapy : CII|January 13, 2012
Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansionMarie Klinge Brimnes, Anne Ortved Gang, Marco Donia, et al.Cancer Immunology, Immunotherapy : CII|July 20, 2006
Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patientRikke Baek Sørensen, Sine Reker Hadrup, Tania Køllgaard, et al.Oncotarget|December 12, 2018
Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanomaJon Bjoern, Rikke Lyngaa, Rikke Andersen, et al.Cancer Biology & Therapy|April 4, 2006
Persistence of survivin specific T cells for seven years in a melanoma patient during complete remissionSine Reker Hadrup, Julie Gehl, Rikke Baek Sørensen, et al.Oncotarget|April 21, 2017
Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanomaJon Bjoern, Rikke Lyngaa, Rikke Andersen, et al.Pageof 10